Table 5. Prevalence and odds ratio (95% confidence interval) of each eGFR category for outcomes in hemorrhagic stroke.
| eGFR (mL/min/1.73 m2) |
|||||
|---|---|---|---|---|---|
| RRT | < 45 | 45–59 | 60–89 | ≥ 90 | |
| (n = 25) | (n = 108) | (n = 153) | (n = 455) | (n = 219) | |
| Death (mRS 6) | |||||
| N (%) | 12 (48) | 46 (42.6) | 35 (22.9) | 92 (20.2) | 42 (19.2) |
| Unadjusted | 3.64 (1.61–8.25) | 2.93 (1.88–4.57) | 1.17 (0.75–1.82) | 1.00 | 0.94 (0.62–1.41) |
| Model 1a | 4.53 (1.92–10.66) | 2.46 (1.56–3.88) | 1.05 (0.67–1.64) | 1.00 | 1.09 (0.72–1.66) |
| Model 2b | 5.27 (1.43–19.50) | 1.66 (0.80–3.42) | 0.85 (0.42–1.72) | 1.00 | 1.00 (0.54–1.83) |
| Death/disability (mRS 2–6) | |||||
| N (%) | 20 (80) | 98 (90.7) | 132 (86.3) | 372 (81.8) | 170 (77.6) |
| Unadjusted | 0.89 (0.33–2.45) | 2.19 (1.09–4.37) | 1.40 (0.84–2.36) | 1.00 | 0.77 (0.52–1.15) |
| Model 1a | 1.30 (0.45–3.77) | 1.61 (0.79–3.28) | 1.20 (0.70–2.05) | 1.00 | 1.04 (0.68–1.58) |
| Model 2b | 0.51 (0.11–2.25) | 0.71 (0.28–1.81) | 1.08 (0.55–2.12) | 1.00 | 1.18 (0.68–2.06) |
eGFR, estimated glomerular filtration rate; RRT, renal replacement therapy; mRS, modified Rankin Scale
a
Adjusted for age and sex
b
Adjusted for age, sex, hypertension, diabetes, myocardial infarction, atrial fibrillation, previous stroke, smoking status, diastolic blood pressure, admission Japan Coma Scale and modified Rankin Scale, intervention/surgery, and recombinant tissue plasminogen activator administration
All regression analyses result are in odds ratio (95% confidence interval)